Immune Checkpoint and Anti-Angiogenic Antibodies for the Treatment of Non-Small Cell Lung Cancer in the European Union and United States

Several types of antibodies (Abs) are currently used in non-small cell lung cancer (NSCLC). Anti-angiogenic and immune checkpoint inhibitor (ICI) Abs are the most frequent treatments used alone or with chemotherapy in metastatic NSCLC, for the front line and beyond. Considering the many therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferreira, Marion, Secher, Thomas, Heuze-Vourc’H, Nathalie, Reckamp, Karen L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234109/
https://www.ncbi.nlm.nih.gov/pubmed/34205484
http://dx.doi.org/10.3390/pharmaceutics13060912

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234109/
https://www.ncbi.nlm.nih.gov/pubmed/34205484
http://dx.doi.org/10.3390/pharmaceutics13060912

Ejemplares similares